Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With PFPS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04748692 |
|
Recruitment Status :
Completed
First Posted : February 10, 2021
Last Update Posted : May 10, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Patellofemoral Pain Syndrome | Procedure: Local exercise therapy Procedure: Spinal manual therapy | Not Applicable |
Interventions
The local exercise therapy group will focus on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients will train with the support of a physiotherapist. The physiotherapist gradually increases the intensity of the exercises improving muscle endurance. The exercises will be supplemented with mobilisations of the patellofemoral joint. Twice a week, patients train at home following a prescribed exercise program writing down their work-out in an exercise journal.
The spinal manual therapy group will be treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots will be used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment will include manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation will be conducted if a restriction of range of motion will be found in any of the regions. Patients will also be asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal.
The allocation of the patients to their treatment group will be concealed from the researcher that assesses the outcome measures.
Outcome measures The following baseline characteristics will be self-reported: age (in years), weight (in kg), height (in cm), duration of symptoms (in months), weekly participation in sport (yes/no), previously receiving exercise therapy treatment for the knee (yes/no). Patellofemoral chondral lesions will be graded using the Kellgren and Lawrence system for classification of osteoarthritis (grade 0 = definite absence of X-ray changes of osteoarthritis, grade 1 = doubtful joint space narrowing and possible osteophytic lipping, grade 2 = definite osteophytes and possible joint space narrowing).
Knee pain, functionality and force will be measured using validated measurement instruments. Pain and functionality will be our primary outcomes. Maximum, minimum and current pain intensity will be indicated on a 0-100 mm VAS line. Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100. Our secondary outcome, maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings. Patients will be assessed before intervention (=baseline), at 6 weeks (=immediately after the last intervention) and at 12 weeks (=6 weeks after the last intervention).
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 43 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | This study is a randomized controlled trial with a follow-up of 6 weeks. Patients with PFPS will be randomly assigned to one of two intervention groups using an online computer-based pseudo-random number generator on which the numbers were generated by use of a complex algorithm (seeded by the computer's clock). The flow diagram of the progress through the phases of the parallel randomised trial of both intervention groups (that is, enrolment, allocation, follow-up, and data analysis) follows the PRISMA statement. |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Masking Description: | The allocation of the patients to their treatment group will be concealed from the researcher that assesses the outcome measures. |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With Patellofemoral Pain Syndrome: Medium Term Follow-up Results of a Randomised Controlled Trial |
| Actual Study Start Date : | October 1, 2016 |
| Actual Primary Completion Date : | January 28, 2021 |
| Actual Study Completion Date : | January 28, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Local exercise therapy
The local exercise therapy group focused on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients trained with the support of a physiotherapist. The physiotherapist gradually increased the intensity of the exercises improving muscle endurance. The exercises were supplemented with mobilisations of the patellofemoral joint. Twice a week, patients trained at home following a prescribed exercise program writing down their work-out in an exercise journal.
|
Procedure: Local exercise therapy
The local exercise therapy group will focus on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients will train with the support of a physiotherapist. The physiotherapist gradually increases the intensity of the exercises improving muscle endurance. The exercises will be supplemented with mobilisations of the patellofemoral joint. Twice a week, patients train at home following a prescribed exercise program writing down their work-out in an exercise journal. |
|
Experimental: Spinal manual therapy
The spinal manual therapy group was treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots were used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment included manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation was conducted if a restriction of range of motion was found in any of the regions. Patients were also asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal.
|
Procedure: Spinal manual therapy
The spinal manual therapy group will be treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots will be used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment will include manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation will be conducted if a restriction of range of motion will be found in any of the regions. Patients will also be asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal. |
- Visual analogue scale [ Time Frame: before the first intervention (at baseline) ]Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.
- Visual analogue scale [ Time Frame: 6 weeks after the first intervention (at 6 weeks) ]Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.
- Visual analogue scale [ Time Frame: 6 weeks after the last intervention (at 12 weeks) ]Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.
- Functionality [ Time Frame: before the first intervention (baseline) ]Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100
- Functionality [ Time Frame: 6 weeks after the first intervention (at 6 weeks) ]Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100
- Functionality [ Time Frame: 6 weeks after the last intervention (at 12 weeks) ]Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100
- Knee extension strength [ Time Frame: before the first intervention (baseline) ]Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.
- Knee extension strength [ Time Frame: 6 weeks after the first intervention (at 6 weeks) ]Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.
- Knee extension strength [ Time Frame: 6 weeks after the last intervention (at 12 weeks) ]Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.
- Age [ Time Frame: before intervention (at baseline) ]self-reported age (in years)
- Weight [ Time Frame: before intervention (at baseline) ]self-reported weight (in kg)
- Height [ Time Frame: before intervention (at baseline) ]self-reported height (in cm)
- Duration of symptoms [ Time Frame: before intervention (at baseline) ]self-reported duration of symptoms (in months)
- Sport [ Time Frame: before intervention (at baseline) ]self-reported weekly participation in sport (Yes/No)
- Previous exercise therapy [ Time Frame: before intervention (at baseline) ]self-reported previous exercise therapy treatment for the knee (Yes/No).
- Chondral lesion [ Time Frame: before intervention (at baseline) ]Grade of patellofemoral chondral lesion (Grade 0, Grade 1, Grade 2) using Kellgren and Lawrence system for classification of osteoarthritis (X-ray)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 16 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- self-reported unilateral or
- bilateral anterior knee pain provoked by at least two of the following activities: jumping, squatting, ascending/ descending stairs, kneeling, prolonged sitting and or a
- positive patellar compression test
Exclusion Criteria:
- experiencing pain for less than 3 months
- a history of knee surgery
- meniscal lesion
- patellar subluxation/dislocation
- evidence of tendinopathy or ligamentous pathologies
- dislocation or fracture in the pelvic region
- spinal surgery
- osteoporosis
- pregnancy
- neurologic disorders
- findings of chondromalacia > grade 2 on MRI, echography or X-ray.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04748692
| Study Chair: | Aldo Scafoglieri, Professor | Vrije Universiteit Brussel |

Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Scafoglieri Aldo, Prof. dr. Aldo Scafoglieri, Vrije Universiteit Brussel |
| ClinicalTrials.gov Identifier: | NCT04748692 |
| Other Study ID Numbers: |
NL57207.096.16 |
| First Posted: | February 10, 2021 Key Record Dates |
| Last Update Posted: | May 10, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | According to GDPR regulations upon reasonable request study results can be shared |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
effectiveness exercise therapy manipulative therapy medium term randimozed controlled trial |
|
Patellofemoral Pain Syndrome Syndrome Disease |
Pathologic Processes Joint Diseases Musculoskeletal Diseases |

